543594 — Dipna Pharmachem Income Statement

0.000.00%

Last trade - 00:00

Basic MaterialsHighly SpeculativeMicro CapValue Trap

Annual income statement for Dipna Pharmachem, fiscal year end - March 31st, INR millions except per share, conversion factor applied.

	2020 March 31st	2021 March 31st	2022 March 31st	2023 March 31st	2024 March 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	PROSPECTUS	PROSPECTUS	PROSPECTUS	ARS	PRESS
Standards:	IAS	IAS	IAS	IAS	—
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	305	310	728	999	1,643
Cost of Revenue
Gross Profit	15.9	14.2	42	44.3	64.2
Selling / General / Administrative Expenses
Depreciation and Amortization
Other Operating Expenses
Total Operating Expenses	301	306	705	976	1,609
Operating Profit	4.39	3.93	22.4	23.3	34.1
Total Net Non Operating Interest Income / Expense
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	0.599	0.55	15.7	13.8	14.2
Provision for Income Taxes
Net Income After Taxes	0.59	0.242	11.7	9.12	10.9
Net Income Before Extraordinary Items
Net Income	0.59	0.242	11.7	9.12	10.9
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	0.59	0.242	11.7	9.12	10.9
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	0.041	0.017	0.801	0.626	0.9